GO:0042102 positive regulation of T cell proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042102 describes any biological process that activates or increases the rate or extent of T cell proliferation, a central event in adaptive immunity.
• T cell proliferation is driven by antigen recognition, costimulation, and cytokine signals, and is tightly regulated by transcription factors, metabolic pathways, and ubiquitin-dependent degradation [1,4,5].
• Dysregulated positive regulation of T cell proliferation contributes to autoimmune diseases, immunodeficiency, and cancer progression [1,8].
• Key molecular players include TGF-beta, NFIL3, ubiquitin-specific proteases, and metabolic enzymes such as pantothenate kinase 4 [1,5,6,7].
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect causal roles of genes in T cell proliferation [4,5].
• Understanding this GO term aids in developing immunotherapies, vaccine adjuvants, and treatments for T cell-driven pathologies [2,3].
Description
Positive regulation of T cell proliferation (GO:0042102) is a fundamental biological process that governs the expansion of T lymphocytes following antigenic stimulation. This process is critical for mounting effective immune responses against pathogens and tumors, and its dysregulation underlies a spectrum of diseases including autoimmunity, immunodeficiency, and leukemia. The QuickGO definition states: "Any process that activates or increases the rate or extent of T cell proliferation." This encompasses signals from the T cell receptor (TCR), costimulatory molecules, cytokines, and intracellular metabolic and transcriptional programs [1,4]. Researchers study this term to identify molecular checkpoints that can be therapeutically targeted to boost immunity or suppress pathological T cell expansion [2,5]. Recent advances have highlighted the roles of ubiquitination, lipid metabolism, and transcription factors such as NFIL3 in controlling T cell proliferation [4,6,7]. Understanding these mechanisms is essential for designing interventions in cancer immunotherapy, autoimmune diseases, and transplantation.
positive regulation of T cell proliferation At A Glance
| GO ID | GO:0042102 |
|---|---|
| GO term | positive regulation of T cell proliferation |
| Ontology | biological_process |
| Synonym | activation of T cell proliferation; positive regulation of T lymphocyte proliferation; stimulation of T cell proliferation; upregulation of T cell proliferation |
| Major function | Increases the rate or extent of T cell proliferation in response to stimuli |
| Related processes | T cell activation, cytokine signaling, cell cycle progression, metabolic reprogramming |
| Disease relevance | Autoimmunity, immunodeficiency, cancer, chronic infection |
| Key regulators | TGF-beta, NFIL3, ubiquitin-specific proteases, pantothenate kinase 4 |
What Is GO:0042102?
GO:0042102, positive regulation of T cell proliferation, refers to any process that activates or increases the rate or extent of T cell proliferation. It includes signaling events, transcriptional changes, and metabolic adaptations that promote the division of T lymphocytes. This term is a child of "regulation of T cell proliferation" and is distinct from negative regulation (GO:0042130). Synonyms include activation of T cell proliferation, stimulation of T cell proliferation, and upregulation of T cell proliferation.
Why Is positive regulation of T cell proliferation Important in Cell Biology?
Positive regulation of T cell proliferation is essential for adaptive immunity, enabling clonal expansion of antigen-specific T cells to combat infections and tumors. Its dysregulation leads to immunopathology, including autoimmune diseases and cancer. Understanding the molecular mechanisms provides targets for immunotherapies, vaccines, and treatments for T cell-mediated disorders [1,3,8].
• Enables effective immune responses against pathogens and tumors.
• Dysregulation causes autoimmune diseases such as Sjogren syndrome.
• Contributes to cancer progression through lipid metabolism and CD8+ T cell function.
• TGF-beta signaling suppresses T cell proliferation, and its inhibition can enhance antitumor immunity.
• Ubiquitination and deubiquitination regulate T cell development and proliferation [4,5].
• Metabolic enzymes like pantothenate kinase 4 support T cell proliferation by modulating coenzyme A and glutaminolysis.
• NFIL3 is involved in cytotoxic T lymphocyte-mediated killing and proliferation.
• Therapies targeting T cell proliferation are used in transplantation and autoimmune diseases.
• Vaccine adjuvants aim to boost T cell proliferation for better protection.
• Single-cell and CRISPR screens identify novel regulators of T cell proliferation [4,5].
What Happens During positive regulation of T cell proliferation?
Antigen Recognition and Costimulation
In simple terms: T cells get activated when they recognize a specific antigen and receive a second signal.
T cell proliferation is initiated when the T cell receptor (TCR) engages a peptide-MHC complex on antigen-presenting cells, providing signal 1. Costimulatory molecules such as CD28 binding to B7 ligands deliver signal 2, which is required for full activation and subsequent proliferation. Without costimulation, T cells may become anergic. This process is tightly regulated by ubiquitination events that control the stability of signaling proteins.
Cytokine Signaling and Transcriptional Activation
In simple terms: Cytokines like IL-2 tell T cells to divide and turn on genes for growth.
Following activation, T cells produce and respond to cytokines such as interleukin-2 (IL-2), which drives proliferation via the JAK-STAT and PI3K-AKT-mTOR pathways. Transcription factors including NF-kB, NFAT, and AP-1 are activated and induce genes involved in cell cycle progression, such as cyclins and CDKs. TGF-beta can inhibit this process by suppressing IL-2 production and cell cycle entry.
Metabolic Reprogramming
In simple terms: Dividing T cells change their metabolism to get energy and building blocks.
Proliferating T cells undergo metabolic reprogramming towards aerobic glycolysis and glutaminolysis to support biomass production. Pantothenate kinase 4 (PANK4) controls coenzyme A levels and lipid synthesis, which are essential for T cell proliferation. Lipid metabolism in CD8+ T cells also influences their proliferation and effector function in cancer.
Cell Cycle Entry and Progression
In simple terms: The cell cycle machinery pushes T cells to divide.
Positive regulation of T cell proliferation ultimately converges on the cell cycle. Cyclin D-CDK4/6 complexes phosphorylate retinoblastoma protein (Rb), releasing E2F transcription factors that drive S-phase entry. This is modulated by ubiquitin-specific proteases that control the stability of cell cycle inhibitors. NFIL3 has been implicated in cytotoxic T lymphocyte proliferation and killing.
Regulation by Ubiquitination and Deubiquitination
In simple terms: Tagging proteins with ubiquitin can turn their activity up or down, affecting T cell division.
Ubiquitination and deubiquitination are critical for T cell development and proliferation. E3 ligases and deubiquitinating enzymes (DUBs) regulate the turnover of key signaling molecules, including TCR components and transcription factors. Ubiquitin-specific proteases (USPs) modulate T cell differentiation and function, and their dysregulation can lead to aberrant proliferation.
Key Genes Involved in GO:0042102 positive regulation of T cell proliferation
The following genes and proteins are key players in the positive regulation of T cell proliferation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB1 | Inhibits T cell proliferation via TGF-beta signaling | Target for enhancing antitumor immunity |
| NFIL3 | Transcription factor promoting cytotoxic T lymphocyte proliferation and killing | Potential target in cancer immunotherapy |
| PANK4 | Regulates coenzyme A and glutaminolysis for lipid synthesis | Metabolic target for modulating T cell proliferation |
| USP1 | Deubiquitinase regulating T cell differentiation and function | Implicated in T cell development and proliferation |
| USP2 | Deubiquitinase modulating T cell signaling | Potential target for autoimmune diseases |
| USP3 | Deubiquitinase involved in T cell activation | Regulates T cell proliferation |
| USP4 | Deubiquitinase affecting T cell responses | Role in T cell proliferation |
| USP5 | Deubiquitinase controlling T cell signaling | Potential therapeutic target |
| USP6 | Deubiquitinase in T cell development | Regulates T cell proliferation |
| USP7 | Deubiquitinase stabilizing key T cell proteins | Target for immunomodulation |
| USP8 | Deubiquitinase involved in TCR downregulation | Affects T cell proliferation |
| USP9X | Deubiquitinase regulating T cell function | Potential target in autoimmunity |
| USP10 | Deubiquitinase modulating T cell signaling | Role in T cell proliferation |
| USP11 | Deubiquitinase in T cell activation | Regulates T cell responses |
| USP12 | Deubiquitinase affecting T cell development | Potential target |
| USP13 | Deubiquitinase in T cell function | Regulates T cell proliferation |
| USP14 | Deubiquitinase controlling T cell signaling | Target for immune modulation |
How Is positive regulation of T cell proliferation Regulated?
Positive regulation of T cell proliferation is controlled by a network of signaling pathways, including TCR signaling, costimulation, cytokine receptors (IL-2, IL-7, IL-15), and metabolic checkpoints. TGF-beta acts as a potent inhibitor, and its blockade enhances T cell proliferation. Ubiquitination and deubiquitination provide reversible control of key signaling proteins [4,5]. Metabolic enzymes such as PANK4 link nutrient availability to proliferation. Transcription factors like NFIL3 and NF-kB integrate these signals to drive cell cycle entry.
positive regulation of T cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFB1 | Autoimmunity, cancer | Knockout mice, conditional overexpression |
| NFIL3 | Cancer immunotherapy | Knockout and knock-in T cells |
| PANK4 | Metabolic regulation of T cell proliferation | Knockout mice, metabolic assays |
| USP1 | T cell development and autoimmunity | Knockout and point mutation models |
| CD8 | Sjogren syndrome | Humanized mouse models |
Autoimmune Diseases
Excessive positive regulation of T cell proliferation contributes to autoimmune diseases such as Sjogren syndrome, where CD8+ T cell depletion promotes Tph/Tfh cell proliferation and disease-like symptoms. Targeting pathways that drive T cell proliferation, such as TGF-beta inhibition, may exacerbate autoimmunity, whereas enhancing TGF-beta signaling could be therapeutic.
Cancer
In cancer, T cell proliferation is often suppressed by the tumor microenvironment. Lipid metabolism in CD8+ T cells regulates their proliferation and effector function, and targeting metabolic pathways such as PANK4 may enhance antitumor immunity [2,6]. NFIL3 supports cytotoxic T lymphocyte-mediated killing, suggesting that its modulation could improve cancer immunotherapy.
Immunodeficiency
Defects in positive regulation of T cell proliferation lead to immunodeficiency, characterized by poor immune responses to infections. Mutations in genes involved in TCR signaling, cytokine production, or metabolic pathways can impair T cell expansion [3,4].
From positive regulation of T cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote T cell proliferation? | Knockout mice or CRISPR KO in primary T cells |
| Does a specific mutation in gene Y affect T cell proliferation? | Point mutation knock-in mice |
| Can overexpression of gene Z enhance T cell proliferation? | Retroviral or lentiviral overexpression |
| What is the role of gene W in T cell metabolism? | Metabolic assays in KO T cells |
| How does gene V regulate T cell differentiation? | CRISPR library screening |
| Does gene U affect T cell proliferation in vivo? | Adoptive transfer experiments |
How to Study the positive regulation of T cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CFSE dilution | Cell division | Tracking T cell proliferation |
| BrdU incorporation | DNA synthesis | Quantifying proliferating cells |
| CRISPR knockout screen | Gene function | Identifying regulators of T cell proliferation |
| RNA-seq | Transcriptional changes | Discovering pathways in proliferating T cells |
| Metabolomics | Metabolite levels | Assessing metabolic reprogramming |
| Flow cytometry | Protein expression | Phenotyping T cell subsets |
| Western blot | Protein levels | Validating ubiquitination targets |
Flow Cytometry
Flow cytometry using CFSE or BrdU labeling is the gold standard to measure T cell proliferation. It allows tracking of cell division and phenotyping of proliferating cells.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify novel regulators of T cell proliferation. These screens are powerful for discovering genes that positively or negatively regulate proliferation [4,5].
Metabolic Assays
Seahorse extracellular flux analysis and metabolomics measure glycolysis, oxidative phosphorylation, and glutaminolysis in proliferating T cells. These assays link metabolic pathways to proliferation.
Transcriptomics and Proteomics
RNA-seq and mass spectrometry-based proteomics reveal transcriptional and post-translational changes during T cell proliferation. They help identify signaling networks and ubiquitination events [4,5].
How CRISPR Can Be Used to Study GO:0042102 positive regulation of T cell proliferation
Knockout
CRISPR knockout of candidate genes in primary T cells or cell lines can determine whether they are required for T cell proliferation. For example, knocking out PANK4 impairs lipid synthesis and proliferation.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to dissect specific phosphorylation or ubiquitination sites. This helps understand how post-translational modifications regulate T cell proliferation.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP, HA) allows tracking of protein expression and localization during T cell proliferation. It can also be used to express mutant proteins under endogenous promoters.
Overexpression
Overexpression of genes such as NFIL3 or PANK4 can enhance T cell proliferation and effector function, providing insights into sufficiency and potential therapeutic applications [6,7].
How EDITGENE Supports positive regulation of T cell proliferation Research
Researchers studying positive regulation of T cell proliferation-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of T cell proliferation research.
Frequently Asked Questions About positive regulation of T cell proliferation
What is GO:0042102?
GO:0042102 is the Gene Ontology term for positive regulation of T cell proliferation, defined as any process that activates or increases the rate or extent of T cell proliferation.
What genes are involved in positive regulation of T cell proliferation?
Key genes include TGFB1, NFIL3, PANK4, and various ubiquitin-specific proteases (USPs) [1,5,6,7].
How is T cell proliferation measured?
Common methods include CFSE dilution, BrdU incorporation, and flow cytometry.
What diseases are associated with dysregulated T cell proliferation?
Autoimmune diseases like Sjogren syndrome, cancer, and immunodeficiency [1,8].
What is the role of TGF-beta in T cell proliferation?
TGF-beta inhibits T cell proliferation and can suppress antitumor immunity.
How does metabolism affect T cell proliferation?
Metabolic pathways such as glycolysis and glutaminolysis provide energy and building blocks for proliferating T cells; PANK4 is a key regulator.
What is the role of ubiquitination in T cell proliferation?
Ubiquitination and deubiquitination control the stability of signaling proteins, thereby regulating T cell proliferation [4,5].
Can CRISPR be used to study T cell proliferation?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in T cell proliferation [4,5].
What is NFIL3 and how does it affect T cells?
NFIL3 is a transcription factor that contributes to cytotoxic T lymphocyte-mediated killing and proliferation.
How does CD8+ T cell depletion affect T cell proliferation?
CD8+ T cell depletion can promote Tph/Tfh cell proliferation and Sjogren syndrome-like symptoms in humanized mice.
Conclusion
Positive regulation of T cell proliferation (GO:0042102) is a central process in adaptive immunity, governed by a complex interplay of antigen recognition, cytokine signaling, metabolic reprogramming, and ubiquitin-dependent regulation. Dysregulation of this process contributes to autoimmunity, cancer, and immunodeficiency. CRISPR-based models and advanced screening technologies are invaluable for dissecting the molecular players involved. EDITGENE provides end-to-end services to support research in this field, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Chen W. 2023. TGF-β Regulation of T Cells.. Annu Rev Immunol 41:483-512 PMID: 36750317
- 2. Tang Y et al.. 2024. Regulation of CD8+ T cells by lipid metabolism in cancer progression.. Cell Mol Immunol 21(11):1215-1230 PMID: 39402302
- 3. Zhang M et al.. 2025. The dynamics of CD4+ T cell proliferation and regulation.. J Biol Dyn 19(1):2458867 PMID: 39881560
- 4. Peng Z et al.. 2024. The Function of Ubiquitination in T-Cell Development.. Adv Exp Med Biol 1466:135-159 PMID: 39546141
- 5. Wang A et al.. 2019. Regulation of T cell differentiation and function by ubiquitin-specific proteases.. Cell Immunol 340:103922 PMID: 31078284
- 6. Hwang JR et al.. 2025. Pantothenate kinase 4 controls lipid synthesis for T-cell proliferation by modulating coenzyme A and glutaminolysis.. Signal Transduct Target Ther 10(1):302 PMID: 40962808
- 7. Douanne T et al.. 2024. NFIL3 contributes to cytotoxic T lymphocyte-mediated killing.. Open Biol 14(2):230456 PMID: 38412963
- 8. Piruzyan M et al.. 2025. CD8+ T cell depletion promotes human Tph/Tfh cell proliferation and Sjögren syndrome-like symptoms in PBMC-based humanized mice.. JCI Insight 10(22) PMID: 41277554
